Digital health refers to the use of digital technologies, such as mobile devices, wearables, and health apps, to improve healthcare delivery, patient outcomes, and population health. Real-world evidence (RWE), on the other hand, refers to data generated from real-world settings, including electronic health records, claims data, patient-generated data, and data from wearable devices, among others.

In the context of digital health, RWE plays a crucial role in demonstrating the value and effectiveness of digital health interventions. For instance, RWE can be used to evaluate the impact of a mobile health app on patient outcomes, such as improved medication adherence or reduced hospital readmissions. RWE can also be used to identify patient populations that may benefit the most from digital health interventions, as well as to assess the feasibility and scalability of such interventions in real-world settings.

Furthermore, RWE can inform regulatory decision-making around digital health products, such as the approval and reimbursement of digital health interventions. For example, the US Food and Drug Administration (FDA) has established a framework for the use of RWE in regulatory decision-making, which includes the use of RWE to support the approval of digital health products.

Overall, digital health and RWE are closely intertwined, with RWE serving as a key component in the development, evaluation, and implementation of digital health interventions.